Hanbin Lin

423 total citations
27 papers, 309 citations indexed

About

Hanbin Lin is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Hanbin Lin has authored 27 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Hanbin Lin's work include Ubiquitin and proteasome pathways (7 papers), Peptidase Inhibition and Analysis (3 papers) and Cancer-related Molecular Pathways (3 papers). Hanbin Lin is often cited by papers focused on Ubiquitin and proteasome pathways (7 papers), Peptidase Inhibition and Analysis (3 papers) and Cancer-related Molecular Pathways (3 papers). Hanbin Lin collaborates with scholars based in China, Canada and Poland. Hanbin Lin's co-authors include Grzegorz Sawicki, Jolanta Sawicka, Virgilio J. J. Cadete, Mieczysław Woźniak, Chen Wai Wong, Patrick Luke, Chris Wojnarowicz, Mike Moser, Yigang Luo and Francisco S. Cayabyab and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and PLoS ONE.

In The Last Decade

Hanbin Lin

27 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanbin Lin China 11 140 56 44 44 33 27 309
Lingling Zhan China 9 127 0.9× 46 0.8× 35 0.8× 53 1.2× 22 0.7× 23 349
Taiji Yoshida Japan 13 170 1.2× 35 0.6× 50 1.1× 87 2.0× 19 0.6× 41 428
Rivka L. Shoulson United States 5 147 1.1× 56 1.0× 17 0.4× 39 0.9× 22 0.7× 7 302
Amr El-Karef Egypt 11 111 0.8× 39 0.7× 28 0.6× 47 1.1× 35 1.1× 19 368
Xi Hong China 10 129 0.9× 78 1.4× 64 1.5× 112 2.5× 14 0.4× 25 376
Xiaoxia Yang China 11 117 0.8× 25 0.4× 43 1.0× 26 0.6× 14 0.4× 26 301
Oli Sarkar Canada 8 137 1.0× 46 0.8× 53 1.2× 23 0.5× 12 0.4× 11 323
Amit Gupta India 10 265 1.9× 46 0.8× 30 0.7× 29 0.7× 14 0.4× 21 381
Yahui Wang China 12 150 1.1× 24 0.4× 70 1.6× 62 1.4× 43 1.3× 27 437
Lian Wang China 10 376 2.7× 61 1.1× 42 1.0× 119 2.7× 18 0.5× 33 668

Countries citing papers authored by Hanbin Lin

Since Specialization
Citations

This map shows the geographic impact of Hanbin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanbin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanbin Lin more than expected).

Fields of papers citing papers by Hanbin Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanbin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanbin Lin. The network helps show where Hanbin Lin may publish in the future.

Co-authorship network of co-authors of Hanbin Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Hanbin Lin. A scholar is included among the top collaborators of Hanbin Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanbin Lin. Hanbin Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Hanbin, Yanan Yu, Xiaojie Wang, et al.. (2025). USP4-mediated CENPF deubiquitylation regulated tumor metastasis in colorectal cancer. Cell Death and Disease. 16(1). 81–81. 1 indexed citations
2.
Lin, Hanbin, et al.. (2025). GLI2-HRD1 axis facilitates 5-FU resistance in gastric cancer cells by regulating ubiquitination degradation of UCK2. Translational Oncology. 58. 102423–102423. 1 indexed citations
3.
Yang, Ruizhi, Yadong Zhao, Hanbin Lin, et al.. (2025). Interface engineering of plant oil body for an innovative food ingredient: A review. Trends in Food Science & Technology. 159. 104954–104954. 11 indexed citations
4.
Zhang, Xiaofeng, Zhanpeng Li, Hanbin Lin, et al.. (2024). A phytoplasma effector destabilizes chloroplastic glutamine synthetase inducing chlorotic leaves that attract leafhopper vectors. Proceedings of the National Academy of Sciences. 121(22). e2402911121–e2402911121. 6 indexed citations
5.
Lin, Hanbin, et al.. (2024). The AKT inhibitor AZD5363 elicits synthetic lethality in ARID1A-deficient gastric cancer cells via induction of pyroptosis. British Journal of Cancer. 131(6). 1080–1091. 1 indexed citations
6.
Lin, Hanbin, et al.. (2024). OTUD1 enhances gastric cancer aggressiveness by deubiquitinating EBV-encoded protein BALF1 to stabilize the apoptosis inhibitor Bcl-2. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(5). 167132–167132. 4 indexed citations
7.
Lin, Hanbin, et al.. (2023). Transcriptional Regulation of Siglec-15 by ETS-1 and ETS-2 in Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences. 24(1). 792–792. 8 indexed citations
8.
Zhang, Qingwei, Xiaojie Wang, Yongchun Chen, et al.. (2023). Development and validation of a novel radiomics nomogram for prediction of early recurrence in colorectal cancer. European Journal of Surgical Oncology. 49(12). 107118–107118. 8 indexed citations
9.
Wang, Wei, Hanbin Lin, Yuanyuan Liu, et al.. (2021). Regulation of survivin protein stability by USP35 is evolutionarily conserved. Biochemical and Biophysical Research Communications. 574. 48–55. 7 indexed citations
10.
11.
Chen, Shenggen, et al.. (2021). Cognitive Function and White Matter Lesions in Medication-Overuse Headache. Journal of Pain Research. Volume 14. 1845–1853. 3 indexed citations
12.
Feng, Jinan, et al.. (2021). Self-stabilizing regulation of deubiquitinating enzymes in an enzymatic activity-dependent manner. International Journal of Biological Macromolecules. 181. 1081–1091. 6 indexed citations
13.
Wu, Qiong, et al.. (2020). Structural and biochemical characterization of inorganic pyrophosphatase from Homo sapiens. Biochemical and Biophysical Research Communications. 533(4). 1115–1121. 6 indexed citations
14.
Lin, Yingying, Jinan Feng, Yuanlin Qi, et al.. (2019). The deubiquitinating enzyme OTUD1 antagonizes BH3-mimetic inhibitor induced cell death through regulating the stability of the MCL1 protein. Cancer Cell International. 19(1). 222–222. 22 indexed citations
15.
Zhao, Zhenhua, Zhiting Chen, Zhang‐Yu Zou, et al.. (2017). DL-3-n-butylphthalide protects endothelial cells against advanced glycation end product-induced injury by attenuating oxidative stress and inflammation responses. Experimental and Therapeutic Medicine. 14(3). 2241–2248. 19 indexed citations
16.
Moser, Mike, Hanbin Lin, Chris Wojnarowicz, et al.. (2016). Protection of the Transplant Kidney from Preservation Injury by Inhibition of Matrix Metalloproteinases. PLoS ONE. 11(6). e0157508–e0157508. 35 indexed citations
17.
Lin, Hanbin, et al.. (2016). Partial purification and characterization of polyphenol oxidase from Chinese parsley (Coriandrum sativum). Food Science and Biotechnology. 25(S1). 91–96. 21 indexed citations
18.
Lin, Hanbin, Keshav Sharma, Magdalena Wawrzyńska, et al.. (2014). Inhibition of MMP-2 expression affects metabolic enzyme expression levels: Proteomic analysis of rat cardiomyocytes. Journal of Proteomics. 106. 74–85. 10 indexed citations
19.
Cadete, Virgilio J. J., et al.. (2013). Synergistic Protection of MLC 1 Against Cardiac Ischemia/Reperfusion-Induced Degradation: A Novel Therapeutic Concept for the Future. Future Medicinal Chemistry. 5(4). 389–398. 9 indexed citations
20.
Lin, Hanbin, Virgilio J. J. Cadete, Jolanta Sawicka, Mieczysław Woźniak, & Grzegorz Sawicki. (2012). Effect of the myosin light chain kinase inhibitor ML-7 on the proteome of hearts subjected to ischemia–reperfusion injury. Journal of Proteomics. 75(17). 5386–5395. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026